Segment Information by Division

January 1 to December 31

 (XLS:) Download XLS

 

 

 

€ million

 

Sili­cones

 

Poly­mers

 

Bio­solutions

 

Poly­silicon

 

Other

 

Discon­tinued opera­tions

 

Consoli­dation

 

Group

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 21.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

2,499.5

 

1,258.2

 

227.0

 

823.5

 

170.6

 

 

 

4,978.8

Internal sales

 

0.1

 

24.0

 

 

 

 

 

-24.1

 

Total sales

 

2,499.6

 

1,282.2

 

227.0

 

823.5

 

170.6

 

 

-24.1

 

4,978.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

536.7

 

108.0

 

9.8

 

-257.3

 

-6.8

 

 

-0.8

 

389.6

Depreciation and impairment losses / reversals

 

79.9

 

39.7

 

13.7

 

329.7

 

77.4

 

 

 

540.4

EBITDA

 

616.6

 

147.7

 

23.5

 

72.4

 

70.6

 

 

-0.8

 

930.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Result from investments in joint ventures and associates

 

31.8

 

 

 

 

99.9

 

 

 

131.7

Impairment of fixed assets

 

 

-1.4

 

 

 

 

 

 

-1.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

222.7

 

71.0

 

17.9

 

62.2

 

87.1

 

 

 

460.9

Additions to financial assets

 

 

 

 

 

 

 

 

Asset additions

 

222.7

 

71.0

 

17.9

 

62.2

 

87.1

 

 

 

460.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,770.3

 

686.3

 

207.1

 

2,262.7

 

2,192.5

 

 

-0.2

 

7,118.7

Liabilities (Dec. 31)

 

826.3

 

307.6

 

78.2

 

712.4

 

2,048.9

 

 

-0.2

 

3,973.2

Net assets (Dec. 31)

 

944.0

 

378.7

 

128.9

 

1,550.3

 

143.6

 

 

 

3,145.5

Investments in joint ventures and associates included in net assets (Dec. 31)

 

41.7

 

 

 

 

616.6

 

 

 

658.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

60.9

 

30.0

 

6.3

 

32.8

 

34.6

 

 

 

164.6

Employees (Dec. 31)

 

5,114

 

1,600

 

709

 

2,549

 

4,570

 

 

 

14,542

Employees (average)

 

4,990

 

1,575

 

665

 

2,548

 

4,523

 

 

 

14,301

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

2,200.0

 

1,225.6

 

205.8

 

1,101.3

 

150.8

 

 

 

4,883.5

Internal sales

 

0.2

 

19.5

 

0.1

 

22.7

 

18.0

 

 

-19.8

 

40.7

Total sales

 

2,200.2

 

1,245.1

 

205.9

 

1,124.0

 

168.8

 

 

-19.8

 

4,924.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

362.2

 

168.1

 

26.1

 

-87.6

 

-48.2

 

 

3.1

 

423.7

Depreciation and impairment losses / reversals

 

82.7

 

37.5

 

11.4

 

378.0

 

80.8

 

 

 

590.4

EBITDA

 

444.9

 

205.6

 

37.5

 

290.4

 

32.6

 

 

3.1

 

1,014.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Result from investments in joint ventures and associates

 

2.0

 

 

 

 

40.0

 

 

 

42.0

Impairment of fixed assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

142.8

 

48.1

 

15.7

 

57.6

 

62.5

 

19.5

 

 

346.2

Additions to financial assets

 

 

 

 

 

0.1

 

 

 

0.1

Asset additions

 

142.8

 

48.1

 

15.7

 

57.6

 

62.6

 

19.5

 

 

346.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,471.1

 

609.3

 

157.7

 

2,395.3

 

2,202.4

 

 

-0.1

 

6,835.7

Liabilities (Dec. 31)

 

688.8

 

270.9

 

66.0

 

759.6

 

1,881.2

 

 

-0.1

 

3,666.4

Net assets (Dec. 31)

 

782.3

 

338.4

 

91.7

 

1,635.7

 

321.2

 

 

 

3,169.3

Investments in joint ventures and associates included in net assets (Dec. 31)

 

9.9

 

 

 

 

554.7

 

 

 

564.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

58.6

 

29.3

 

6.0

 

22.6

 

36.6

 

 

 

153.1

Employees (Dec. 31)

 

4,737

 

1,539

 

533

 

2,538

 

4,464

 

 

 

13,811

Employees (average)

 

4,708

 

1,519

 

528

 

2,527

 

4,441

 

 

 

13,723

todo Vorjahresvergleich